| Application no. and date | 20765424.5 (espacenet) (Federated) (European Patent Register), 20200821 | | Patent/reg. no. and date | DK/EP 4017871, 20240117 | | Publication date | 20220629 | | Priority no. and date | US 201962889749 P, 20190821, US 202063014934 P, 20200424, US 202063022843 P, 20200511 | | EP pub. no. and date |
EP 4017871 20220629 | | Effective date | | | Applicant/owner | Research Institute at Nationwide
Children's Hospital, 700 Children's Drive, Room W172,
Columbus, Ohio 43205, US | | Applicant ref. no. | 1693786 | | Inventor | MENDELL, Jerry, R., 8176 Copperfield Drive
Columbus, OH 43235, US,
RODINO-KLAPAC, Louise, 5499 Lilac Ave.
Grove City, OH 43123, US,
GRIFFIN, Danielle, 8927 Shady Woods St. Canal
Winchester, OH 43110, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 48/00 (2006.01) , C07K 14/47 (2006.01) , C12N 15/86 (2006.01) | | Title | ADENOASSOCIERET VIRUSVEKTORADMINISTRATION AF ALFA-SARCOGLYCAN OG BEHANDLING AF MUSKELDYSTROFI | | Int. application no. | US2020047339 | | Int. publication no. | WO2021035120 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
